SYNG Pharmaceuticals
ON - KingstonDiagnostics
Focus: SYNG Pharmaceuticals is a Kingston, ON-based diagnostic and peptide-based therapeutic company focused on non-hormonal endometriosis treatment, operating at the intersection of women's health and neurology. Founded in 2018 and publicly traded, the company specializes in diagnostic innovation and targeted peptide therapeutics.
Profile data last refreshed 7h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About SYNG Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow SYNG Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from SYNG Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2018
Help build intelligence for SYNG Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.